This site is intended for health professionals only

At the heart of general practice since 1960

pul jul aug2020 cover 80x101px
Read the latest issue online

Independents' Day

Half of practices haven't begun reviews of incorrect QRISK scores

NHS England has warned that more than 1,000 practices have not yet checked lists of patients who may need treatment reviews after being given incorrect cardiovascular risk scores following a major IT bug.

NHS England director of general practice Dr Arvind Madan has contacted the GPC to warn that about half of the 2,500 SystmOne practices affected by the error have not yet accessed lists of affected patients.

The lists were sent to practices in May, and GPs were told it was their responsibility to contact and review any patients who may need to be put on statins, or cease treatment, as a result of the IT error. 

Both NHS England and GPC are conducting reviews to determine how much practices should be recompensed due to the added workload.

The GPC has said it would be ‘difficult to defend’ practices who have not yet checked their affected patients.

In an email to LMCs last month, GPC clinical lead Dr Andrew Green said: ‘I have spoken today with Dr. Arvind Madan from NHS England, who is concerned that about half of practices affected by this issue have not accessed the lists NHSE has provided them of their affected patients.

‘I would agree with him that practices should be aware of who these patients are and that it would be difficult to defend a practice that had not done so.’

Dr Green’s email to LMCs included a workload survey, which the GPC will use to argue for recompense from SystmOne provider TPP.

NHS England also pledged to audit the workload burden of reviewing patients and re-consulting with those who need a change to their treatment.

Pulse revealed that hundreds of thousands of patients may have been inappropriately started on statins, or kept off the treatment, because of a bug with the QRISK2 tool in SystmOne that dated back to 2009.

As a result, the DH stepped in to prevent NHS organisations and arms lengths bodies negotiating new contracts with TPP, with NHS England later confirming that 260,000 patients were affected.

NHS England said that an average practice would have 100 patients affected, though most of these would not need further action after they were reviewed.

It has already set out how practices should review these patients.

Readers' comments (2)

  • Does this just reflect busy workload?

    Or is it a sign that some of us think that statins for primary prevention may be a bit of a waste of time, even for some patients above the 20% risk threshold?

    Unsuitable or offensive? Report this comment

  • In my Practice we have reviewed patients as reported. All this confirmed was that Qrisk is a rabbish prediction tool. Everyone over 75 is high risk, yet 55 y o with cholesterol of 8 isn't according to it. Another example of people from the ivory tower getting it wrong again.

    Unsuitable or offensive? Report this comment

Have your say